Atlas Trials

Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes

Clinical trial NCT01059799 · COMPLETED

Trial details

NCT number
NCT01059799
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2010-02-01
Primary completion
2010-12-16
Enrollment
435

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.